Advanced Malignancies

Showing NaN - NaN of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting
  • Advanced Malignancies
  • +4 more
  • Fayetteville, Arkansas
  • +61 more
Jan 10, 2023

Advanced Malignancies, Metastatic Cancer Trial in Worldwide (INCAGN01876, Nivolumab, Ipilimumab)

Completed
  • Advanced Malignancies
  • Metastatic Cancer
  • Los Angeles, California
  • +37 more
Dec 6, 2022

Advanced Malignancies Trial in Belgium, Spain, United States (INCA32459-101)

Recruiting
  • Advanced Malignancies
  • Los Angeles, California
  • +14 more
Dec 1, 2022

All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

Active, not recruiting
  • All Malignancies
  • +11 more
  • Encinitas, California
  • +9 more
May 20, 2022

NSCLC, Lung Cancer, Advanced Malignancies Trial in Worldwide (Brigatinib, Crizotinib)

Completed
  • Non-small Cell Lung Cancer
  • +3 more
  • Sedona, Arizona
  • +90 more
Jul 27, 2021

Advanced Malignancies, Metastatic Cancer Trial in Worldwide (INCAGN01949)

Completed
  • Advanced Malignancies
  • Metastatic Cancer
  • New Brunswick, New Jersey
  • +7 more
May 6, 2020

Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,

Completed
  • Advanced Cancer
  • Advanced Malignancies
  • Gilbert, Arizona
  • +46 more
Jan 23, 2020

Advanced Malignancies Trial in Barcelona, Valencia (alisertib)

Completed
  • Advanced Malignancies
  • Barcelona, Spain
  • +1 more
Nov 29, 2018

Advanced Malignancies Trial in Barcelona (MLN8054)

Terminated
  • Advanced Malignancies
  • Barcelona, Spain
    Ciutat Sanitaria Vall d'Hebron
Sep 20, 2013